References
- Bender AS, Neary JT, Blicharska LO, Norenberg LO, Norenberg MD. 1992. Role of calmodulin and protein kinase C in astrocytic cell volume regulation. J Neurochem 58:1874–1882.
- Berridge MJ, Bootman MD, Roderick HL. 2003. Calcium signalling: dynamics, homeostasis and remodelling. Nat Rev Mol Cell Biol 4:517–529.
- Bowman ZS, Morrow JD, Jollow DJ, McMillan DC. 2005. Primaquine-induced hemolytic anemia: role of membrane lipid peroxidation and cytoskeletal protein alterations in the hemotoxicity of 5-hydroxyprimaquine. J Pharmacol Exp Ther 314:838–845.
- Carafoli E. 1982. Membrane transport of calcium. London: Academic Press Inc. Ltd.
- Claas SA, Glasser SP. 2005. Long-acting diltiazem HCl for the chronotherapeutic treatment of hypertension and chronic stable angina pectoris. Expert Opin Pharmacother 6:765–776.
- Cossins AR, Gibson JS. 1997. Volume sensitive transport systems and volume homeostasis in vertebrate red blood cells. J Exp Biol 200:343–352.
- Dong Z, Saikumar P, Weinburg JM, Venkatachalam MA. 2006. Calcium in cell injury and death. Annu Rev Pathol Mech Dis 1:405–434.
- Freedman MP. 2000. Autoimmune haemolytic anaemia: a history. Transfusion Med Rev 14:223–233.
- Garcia-Romeu F, Cossins AR, Motais R. 1991. Cell volume regulation by trout erythrocytes – characteristics of the transport systems activated by hypotonic swelling. J Physiol 440:547–567.
- Gardos G. 1958. The function of calcium in the potassium permeability of human erythrocytes. Biochim Biophys Acta 30:653–654.
- Gibson JS, Hall AC. 1995. Stimulation of the KCl co-transport in equine erythrocytes by hydrostatic pressure: the effects of kinase/ phosphatase inhibition. Pflugers Archiv 429:446–448.
- Hoffbrand AV, Pettit JE, Moss PAH. 2001. Essential haematology. 4th ed. Oxford: Blackwell Science.
- Hoffman EK. 1992. Cell swelling and volume regulation. Can J Physiol Pharmacol 70:310–313.
- Holden C. 2003. Genetics. First cloned mule races to finish line. Science 300:1354.
- Lang F, Busch GL, Ritter M, Volkl H, Waldegger S, Gulbins E, Haussinger D. 1998. Functional significance of cell volume regulatory mechanisms. Physiol Rev 78:247–306.
- Okada Y, Maeno E, Shimizu T, Dezaki K, Wang J, Morishima S. 2001. Receptor-mediated control of regulatory volume decrease (RVD) and apoptotic volume decrease (AVD). J Physiol 532:3–16.
- Petz LD. 1980. Drug-induced haemolytic anaemia. Clin Haematol 9:455–482.
- Raess BU, Gersten MH. 1987. Calmodulin-stimulated plasma membrane (Ca2+ +Mg2+)-ATPase: inhibition by calcium channel entry blockers. Biochem Pharmacol 36:2455–2459.
- Raess BU, Record DM. 1990. Inhibition of erythrocyte calcium pump by calcium antagonists. Biochem Pharmacol 40:2549–2555.
- Ramoska EA, Spiller HA, Winter M, Borys D. 1993. A one-year evaluation of calcium channel blocker overdoses: toxicity and treatment. Anal Emerg Med 22:196–200.
- Rang HP, Dale MM, Ritter JM. 1999. Pharmacology. Edinburgh: Church Livingstone.
- Romero PJ, Romero EA. 1999. The role of calcium metabolism in human red blood cell ageing: a proposal. Blood Cells Mol Dis 25:9–19.
- Salamino F, Sparatore B, Melloni E. 1994. The plasma membrane calcium pump is the preferred calpain substrate within the erythrocytes. Cell Calcium 15:28–35.
- Schatzmann HJ. 1975. Active calcium transport and calcium ion activated ATPase in human red blood cells. Curr Topics Membr Trans 6:125–168.
- Vanderklish PW, Bahr BA. 2000. The pathogenic activation of calpain: a marker and mediator of cellular toxicity and disease states. Int J Exp Pathol 81:323–339.
- Watts TJ, Handy RD. 2007. The haemolytic effect of verapamil on erythrocytes exposed to varying osmolarity. Toxicol in Vitro 21:835–839.